Libby Sweeney is a former credit cards editor for Forbes Advisor. Her previous experience writing and editing content for readers to better understand includes both the world of sports and data ...
The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...
Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback